Vext Science, Inc.
VEXT
CNSX
Weiss Ratings | VEXT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | D | |||
Rating Factors | VEXT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Fair | |||
Solvency Index | Good | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | VEXT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.07 | |||
Price History | VEXT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 3.45% | |||
30-Day Total Return | -9.09% | |||
60-Day Total Return | -6.25% | |||
90-Day Total Return | -18.92% | |||
Year to Date Total Return | -11.76% | |||
1-Year Total Return | -36.17% | |||
2-Year Total Return | -42.31% | |||
3-Year Total Return | -72.73% | |||
5-Year Total Return | -78.57% | |||
52-Week High % Change | -60.53% | |||
52-Week Low % Change | 15.38% | |||
Price | VEXT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.38 | |||
52-Week Low Price | $0.13 | |||
52-Week Low Price (Date) | Feb 11, 2025 | |||
52-Week High Price (Date) | Apr 30, 2024 | |||
Valuation | VEXT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 25.80M | |||
Enterprise Value | 61.00M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.03 | |||
Earnings Per Share Growth | -185.71% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 1.09 | |||
Price/Book (Q) | 0.43 | |||
Enterprise Value/Revenue (TTM) | 1.78 | |||
Price | $0.15 | |||
Enterprise Value/EBITDA (TTM) | -35.80 | |||
Enterprise Value/EBIT | -3.83 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | VEXT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 248.66M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | VEXT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | -- | |||
Address | 4152 N. 39th Ave. Phoenix, AZ 85019 | |||
Website | www.vextscience.com | |||
Country | United States | |||
Year Founded | 2015 | |||
Profitability | VEXT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -46.59% | |||
Profit Margin | -22.18% | |||
Management Effectiveness | VEXT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -7.62% | |||
Return on Equity | -- | |||
Income Statement | VEXT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 34.22M | |||
Total Revenue (TTM) | 34.22M | |||
Revenue Per Share | $0.14 | |||
Gross Profit (TTM) | 8.72M | |||
EBITDA (TTM) | -1.70M | |||
EBIT (TTM) | -15.94M | |||
Net Income (TTM) | -7.59M | |||
Net Income Avl. to Common (TTM) | -7.59M | |||
Total Revenue Growth (Q YOY) | 10.96% | |||
Earnings Growth (Q YOY) | -35.83% | |||
EPS Diluted (TTM) | -0.03 | |||
EPS Diluted Growth (Q YOY) | 17.07% | |||
Balance Sheet | VEXT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 2.84M | |||
Cash Per Share (Q) | $0.01 | |||
Total Current Assets (Q) | 28.50M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 84.90M | |||
Current Ratio (Q) | 1.649 | |||
Book Value Per Share (Q) | $0.35 | |||
Total Assets (Q) | 143.46M | |||
Total Current Liabilities (Q) | 17.29M | |||
Total Debt (Q) | 40.33M | |||
Total Liabilities (Q) | 58.56M | |||
Total Common Equity (Q) | 84.90M | |||
Cash Flow | VEXT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -6.45M | |||
Cash from Financing (TTM) | 5.78M | |||
Net Change in Cash (TTM) | -780.10K | |||
Levered Free Cash Flow (TTM) | 14.55M | |||
Cash from Operations (TTM) | -110.90K | |||